The Influence of Vaginal Native Tissue Repair (VNTR) on Various Aspects of Quality of Life in Women with Symptomatic Pelvic Organ Prolapse-A Prospective Cohort Study.
pelvic organ prolapse
quality of life
stool incontinence
urinary incontinence
vaginal native tissue repair
Journal
Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588
Informations de publication
Date de publication:
28 May 2020
28 May 2020
Historique:
received:
27
04
2020
revised:
20
05
2020
accepted:
26
05
2020
entrez:
3
6
2020
pubmed:
3
6
2020
medline:
3
6
2020
Statut:
epublish
Résumé
Pelvic organ prolapse (POP) and the associated functional disorders are a major epidemiological problem that compromises the quality of life (QoL). The aim of this study was to assess the impact of lower urinary tract symptoms (LUTS) related to POP and vaginal native tissue repair (VNTR) on QoL. Two hundred patients with symptomatic POP were stratified into four groups according to the dominant storage phase function disorders: Urgency; stress urinary incontinence (SUI); mixed urinary incontinence (MUI), and without clinically significant symptoms from lower urinary tract (LUT). They underwent VNTR from January 2018 to February 2019. After 12 months, the QoL was assessed by the Prolapse Quality of Life (P-QoL) and visual analogue scale (VAS) questionnaires. The data were analyzed with Statistica package version 12.0 (StatSoft, Krakow, Poland), using the Kalmogorow-Smirnoff, Shapiro-Wilk W and the one-way analysis of variance with post hoc Tukey tests. The results of P-QoL showed significant improvement (
Identifiants
pubmed: 32481614
pii: jcm9061634
doi: 10.3390/jcm9061634
pmc: PMC7355538
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Am J Obstet Gynecol. 2004 Jul;191(1):165-70
pubmed: 15295359
Curr Urol Rep. 2017 Jan;18(1):6
pubmed: 28155202
Female Pelvic Med Reconstr Surg. 2014 Nov-Dec;20(6):322-7
pubmed: 25185629
BJU Int. 2019 Mar;123(3):493-510
pubmed: 29908047
Am J Obstet Gynecol. 2003 Aug;189(2):372-7; discussion 377-9
pubmed: 14520198
Am J Obstet Gynecol. 1996 Jul;175(1):10-7
pubmed: 8694033
Int Urogynecol J. 2013 Jul;24(7):1127-34
pubmed: 23152049
J Clin Med. 2020 Mar 18;9(3):
pubmed: 32197495
Ultrasound Obstet Gynecol. 2007 Apr;29(4):368-71
pubmed: 17390304
Cochrane Database Syst Rev. 2016 Feb 09;2:CD012079
pubmed: 26858090
Health Technol Assess. 2016 Dec;20(95):1-452
pubmed: 28052810
Int Urogynecol J. 2015 Nov;26(11):1649-56
pubmed: 26143226
Am J Obstet Gynecol. 2011 May;204(5):441.e1-5
pubmed: 21292234
BJOG. 2012 Feb;119(3):354-60
pubmed: 22239416
Int Urogynecol J. 2017 Aug;28(8):1115-1118
pubmed: 28624917
BJOG. 2020 Jan;127(1):28-35
pubmed: 31541614
Ginekol Pol. 2016;87(7):477-83
pubmed: 27504938
Neurourol Urodyn. 2010;29(1):30-9
pubmed: 20025017
Am J Obstet Gynecol. 2006 Dec;195(6):1837-40
pubmed: 17132485
Behav Res Methods. 2007 May;39(2):175-91
pubmed: 17695343
Int Urogynecol J. 2013 Nov;24(11):1783-90
pubmed: 24142054
Neurourol Urodyn. 2002;21(2):167-78
pubmed: 11857671
Int Urogynecol J. 2014 Feb;25(2):279-84
pubmed: 24030216
Int Urogynecol J. 2013 Nov;24(11):1815-33
pubmed: 24142057
Int Urogynecol J. 2019 Jul;30(7):1147-1152
pubmed: 29869693
Ultrasound Obstet Gynecol. 2014 Jun;43(6):693-7
pubmed: 24127311
Acta Obstet Gynecol Scand Suppl. 1990;153:7-31
pubmed: 2093278
Obstet Gynecol. 2009 Mar;113(3):609-16
pubmed: 19300324